(E)-2-Mercapto-5-(4-methylbenzylidene)thiazol-4(5H)-one

Catalog No. :
ACVDSB706
CAS No. :
33992-80-2
Molecular Formula :
C11H9NOS2
Molecular Weight :
235.33

IUPAC Name:(E)-5-(4-methylbenzylidene)-2-thioxothiazolidin-4-one

(E)-2-Mercapto-5-(4-methylbenzylidene)thiazol-4(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$128.00Login to see priceInquiryInquiry
5g95%$512.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-2-Mercapto-5-(4-methylbenzylidene)thiazol-4(5H)-one
IUPAC Name(E)-5-(4-methylbenzylidene)-2-thioxothiazolidin-4-one
MDL No.MFCD04969042
Molecular FormulaC11H9NOS2
Molecular Weight235.33
SMILESO=C1N=C(S)S/C1=C/C2=CC=C(C)C=C2
InChI KeyRAXPMQHOSGNELK-RMKNXTFCSA-N
SynonymAlbb-009123;(5E)-2-mercapto-5-(4-methylbenzylidene)-1,3-thiazol-4(5H)-one(SALTDATA: FREE);(5Z)-5-(4-methylbenzylidene)-2-thioxo-thiazolidin-4-one;(5Z)-5-[(4-methylphenyl)methylene]-2-thioxo-4-thiazolidinone;(5Z)-5-[(4-methylphenyl)methylene]-2-thioxo-thiazolidin-4-one;(5Z)-5-[(4-methylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one;5-(4-methylbenzylidene)-2-thioxo-thiazolidin-4-one;AKOS B018339
CAS No.33992-80-2

Synthetic Route by SureRoute

1. ACVDSB706 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKOVF910 route compound structure diagram
    ACKOVF910104-87-0 In Stock
  2. Plus
  3. ACADET348 route compound structure diagram
    ACADET348141-84-4 In Stock
  4. Then
  5. ACVDSB706 route product structure diagram
    ACVDSB70633992-80-2
Inquiry

2. ACVDSB706 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOZNU129 route compound structure diagram
    ACOZNU129624-31-7 In Stock
  4. Then
  5. ACVDSB706 route product structure diagram
    ACVDSB70633992-80-2
Inquiry

Comments (0)